Recordati Industria Chimica e Farmaceutica S.p.A. (LON:0KBS)

Market Cap	9.15B
Revenue (ttm)	1.94B
Net Income (ttm)	344.43M
Shares Out	n/a
EPS (ttm)	n/a
PE Ratio	26.55
Forward PE	n/a
Dividend	1.04 (1.75%)
Ex-Dividend Date	Nov 18, 2024

Volume	12,936
Average Volume	46,174
Open	55.13
Previous Close	54.85
Day's Range	53.95 - 54.95
52-Week Range	39.18 - 45.39
Beta	0.45
RSI	36.04
Earnings Date	Feb 21, 2025

About LON:0KBS

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceuticals in Italy and internationally. It operates through Specialty and Primary Care and Rare Diseases segments. The company’s product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing’s syndrome; and CYSTADROPS for the treatment of cystine crystal deposits...

• Industry: Pharmaceutical Preparations
• Founded: 1926
• Employees: 4,450
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0KBS

Financial Performance

In 2024, LON:0KBS's revenue was 2.34 billion, an increase of 12.45% compared to the previous year's 2.08 billion. Earnings were 416.50 million, an increase of 7.01%.

Financial numbers in EUR